• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Japan’s Role in Shaping OECD Non-Animal Test Guidelines

by
November 10, 2026
in Biology
Reading Time: 6 mins read
0
Japan's Role in Shaping OECD Non-Animal Test Guidelines

Japan's Role in Shaping OECD Non-Animal Test Guidelines

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A review published in the journal Genes and Environment details the historical trajectory of Japan’s contributions to the Organisation for Economic Co-operation and Development (OECD) test guidelines for non-animal test methods. The study, authored by Hajime Kojima, examines how the National Institute of Health Sciences (NIHS) and other Japanese entities have standardized international protocols for chemical safety testing. As of November 2024, non-animal test methods account for more than 40% of the test methods within the OECD Guidelines for the Testing of Chemicals (TGs) related to human health. This review highlights the specific mechanisms through which Japan advanced these methodologies, moving from initial validation efforts to the formal adoption of international standards that reduce reliance on animal testing in regulatory contexts.

The development of non-animal testing methods began in the 1960s, initially targeting the replacement of Draize eye or skin irritation tests and acute toxicity tests. These early efforts were driven by the 3Rs principle proposed by Russel and Barch in 1959, which advocates for reducing the number of animals used, refining procedures to minimize pain, and replacing animals with non-animal systems. In the 1990s, large-scale validation studies were conducted by cosmetic industry associations in Europe and the United States, focusing on eye irritation tests. Simultaneously, collaborative research on cytotoxicity tests was pursued in Sweden as an alternative to acute toxicity assessments, while German institutions led the validation of alternative methods for corrosivity tests.

Japan’s involvement in this international framework was catalyzed by the establishment of the Japanese Centre for the Validation of Alternative Methods (JaCVAM) within the NIHS in 2005. Prior to this, validation studies in Japan, such as those led by Dr. Yasuo Ohno and the Japan Cosmetic Industry Association, faced challenges including a lack of independent peer review and incomplete data sheets. These early difficulties informed the structural improvements that defined JaCVAM’s subsequent operations. The centre was created to promote alternative methods in regulatory studies, adhering to the 3Rs principle and fulfilling the NIHS’s responsibility to protect the public by assessing the safety of chemicals and other materials.

JaCVAM’s mission involves evaluating the utility, limitations, and suitability of test methods for regulatory studies. It conducts validation studies and independent peer reviews to ensure that methods meet international standards. This work has resulted in the development of over 20 validation reports and peer-reviewed reports, some of which were developed by other countries or the OECD and supported by the International Cooperation on Alternative Test Methods (ICATM). ICATM, established in 2009 by JaCVAM, the US Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the European Centre for the Validation of Alternative Methods (ECVAM), and Health Canada, aims to foster international cooperation in validation studies and harmonized recommendations.

One of Japan’s significant contributions was the validation of skin sensitization tests, specifically the Local Lymph Node Assay (LLNA)-Daicel (DA) and the LLNA: BrdU-ELISA. These methods were developed by Daicel Corporation and the Chemicals Evaluation and Research Institute, respectively, and were officially established by the OECD in 2010 as TG442A and TG442B. The validation results were independently reviewed by ICCVAM, which facilitated their acceptance into the OECD guidelines. This process demonstrated the importance of international peer review in securing regulatory acceptance for new test methods, providing a model for future validations.

In the area of eye irritation testing, Japanese corporations have played a pivotal role in developing and validating alternative methods. The Short Time Exposure in vitro Test Method (TG491) was developed by Kao Corporation, while J-TEC Corporation developed the Reconstructed human Cornea-like Epithelium Test Method (TG492). These methods are designed to identify chemicals that do not require classification and labeling for eye irritation or serious eye damage. Additionally, the Vitrigel®-Eye Irritancy Test Method (TG494), developed by Toshikaki Takezawa and Kanto Chemical Co., Inc., evaluates eye irritation over a short time period. These methods have expanded the market for non-animal tests and provided robust alternatives to traditional animal-based assessments.

Japan has also contributed to the development of skin sensitization and immunotoxicity assays. The h-CLAT assay, developed by Kao Corporation and Shiseido Co., Ltd., was part of a broader effort to include various in chemico or in vitro Skin Sensitization tests in OECD guidelines TG442C to TG442E. Building on this foundation, researchers at Tohoku University, including Drs. Setsuya Aiba and Yutaka Kimura, introduced the world’s first non-animal immunotoxicity assay, TG444A In vitro immunotoxicity IL-2 Luc assay.

The review notes that while 31 in chemico or in vitro test methods have been adopted as alternative methods among 76 OECD TGs related to human health, these methods are primarily limited to skin irritation, phototoxicity, eye irritation, genotoxicity, and endocrine disruptor screening. They contribute mainly to the United Nations globally harmonized system of classification and labeling of chemicals (UN GHS). However, few methods for detecting systemic toxicity have been accepted by the OECD. This limitation highlights the ongoing need for new approach methodologies that can address more complex toxicological endpoints.

Despite these achievements, the process of establishing new test guidelines has not been without challenges. The Bhas 42 Cell Transformation Assay, for instance, could not be converted into a TG due to insufficient results from international validation. The assay remains limited to the OECD Series on Testing & Assessment No. 231. Additionally, several validated methods, such as the SIRC-CVS for eye irritation and the Bovine Corneal Opacity and Permeability Test Method, have yet to be accepted within the OECD TG program. These outcomes underscore the rigorous standards required for international regulatory acceptance and the importance of robust data and independent peer review.

JaCVAM continues to collaborate with international organizations and test developers to advance non-animal testing methods. The centre is currently conducting validation studies on skin irritation test methods for medical devices and non-animal test methods for the pyrogenicity assay in the Japanese Pharmacopeia. These efforts reflect the increasing demand for non-animal test methods from international organizations other than the OECD. By leveraging its experience in validation and international cooperation, Japan aims to contribute to the development of new approach methodologies for systemic toxicity tests worldwide, addressing a critical gap in current safety assessment practices.

In 1996, international experts met at the Solna Workshop to agree upon foundational principles and criteria for the validation and regulatory acceptance of new toxicological methods. To resolve earlier ambiguities where validations were conducted at the discretion of individual groups, the OECD held a follow-up conference in Stockholm in March 2002, focusing on hazard assessment standards. These efforts culminated in the 2005 publication of OECD Guidance Document No. 34, which defined validation as establishing the reliability and relevance of a specific test method. Alongside earlier institutional milestones, such as the creation of the Interagency Coordinating Committee on the Validation of Alternative Methods in the United States in 1991 and the European Center for the Validation of Alternative Methods in 1997, the international framework expanded further when validation centres from South Korea and Brazil joined the International Cooperation on Alternative Test Methods.

Beyond individual test protocols, the international landscape encompasses 75 validated non-animal test methods distributed across 31 adopted guidelines for human health. Because individual non-animal assays often exhibit narrow applicability domains that cannot single-handedly determine complete hazard classifications under the United Nations Globally Harmonized System, regulatory strategies increasingly rely on defined approaches. For instance, Guideline 497, issued in 2021, integrates multiple non-animal test guidelines for skin sensitization to determine category 1A, category 1B, or non-category classifications. Similarly, Test Guideline 467 establishes a defined approach for serious eye damage and eye irritation, enabling category 2 weak-irritation classification through combined testing and computational in silico tools from OECD toolboxes. These multi-test frameworks operate alongside formalized good in vitro method practices designed to ensure high quality and consistency across experimental studies.

Within Japan, early collaborative initiatives through the Japanese Society of Alternative Methods for Animal Experiments helped refine national testing protocols. A collaborative eye irritation validation involving over 50 participating institutions, led by Dr. Tadao Ohno of the RIKEN BioResource Research Center, highlighted administrative hurdles when incomplete data sheets extended biostatistical analysis for over a year. Subsequent partnerships addressed these obstacles, including collaboration between the Japanese Environmental Mutagen and Genome Society MMS Study Group, the National Institute of Health Sciences, and industry specialists Dr. Makoto Hayashi and Dr. Yoshifumi Uno. Their international coordination on an alkaline comet assay targeting the stomach and intestine successfully established Test Guideline 489 in 2014. Japanese developers also broadened tissue modeling, as J-TEC Corporation validated reconstructed human epidermis protocols under Test Guideline 431 for skin corrosion and Test Guideline 439 for skin irritation using LabCyte EPI-MODEL24.

Japan’s regulatory footprint also includes developing the reactive oxygen species assay under the International Council for Harmonisation S10 photosafety guidance, alongside assays like the Amino Acid Derivative Reactivity Assay and EpisensA under Test Guidelines 442C to 442E. JaCVAM governance relies on its steering, editorial, and regulatory acceptance committees, which have submitted over 40 recommended methods to the Ministry of Health, Labour and Welfare. However, international harmonization created friction when protocol revisions threatened developers’ published data, while several methods, including the Hand1 Luc embryonic stem cell test and the IL-1α Luc immunotoxicity assay, remain unaccepted by the OECD.

Subject of Research: History of the Organisation for Economic Co-operation and Development (OECD) test guidelines for non-animal test methods in Japan

Article Title: History of the Organisation for Economic Co-operation and Development (OECD) test guidelines for non-animal test methods in Japan

Article References: Kojima, H. (2025). History of the Organisation for Economic Co-operation and Development (OECD) test guidelines for non-animal test methods in Japan. Genes and Environment, 47(1), Article 3. https://doi.org/10.1186/s41021-024-00323-7

Image Credits: AI Generated

DOI: 10.1186/s41021-024-00323-7

Keywords: History, Organisation, Economic, Co-operation, Development, OECD, test, guidelines, non-animal, methods, Japan, scientific research

News Source: Drew Townsend. (November 10, 2026). Japan’s Role in Shaping OECD Non-Animal Test Guidelines. Scienmag.

Tags: Co-operationDevelopmenteconomicguidelinesHistoryJapanmethodsnon-animalOECDOrganisationscientific researchtest
Share12Tweet7Share2ShareShareShare1

Related Posts

Experiential Workshop Expands Mexican Students' Understanding of Bat Diets and Ecological Roles

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

November 17, 2026
Engineered Escherichia Coli Produces C14-Enriched Lipid Adjuvant Homologs in Bioreactor Batches

Engineered Escherichia Coli Produces C14-Enriched Lipid Adjuvant Homologs in Bioreactor Batches

November 17, 2026

Swine Fever Virus Disrupts Blood-Testis Barrier Integrity in Laboratory Models

November 17, 2026

Natural History Museum Digitizes Hundreds of Jason Londt Robber Fly Types

November 17, 2026

POPULAR NEWS

  • Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    29 shares
    Share 12 Tweet 7
  • Gut Microbiota and Metabolites Influence Immunotherapy Response in Liver Cancer

    29 shares
    Share 12 Tweet 7
  • Nonlinear Sex-Specific Remodeling of the TCRβ Repertoire During Adult Aging

    29 shares
    Share 12 Tweet 7
  • Capped Nanovials Enable Extended Cell Growth and Screening in UCLA Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.